LAUREN WHEELER: Open Payments
NPI 1386091775 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,950 in 166 payments from 21 companies in 2025. Trend: 2023 $5,492 · 2024 $4,969 · 2025 $3,950
Food & beverage: $3,850Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 40 | $753 |
| ABBVIE INC. | 34 | $676 |
| UCB, Inc. | 19 | $488 |
| AstraZeneca Pharmaceuticals LP | 9 | $398 |
| Novartis Pharmaceuticals Corporation | 15 | $312 |
| GlaxoSmithKline, LLC. | 17 | $264 |
| Janssen Biotech, Inc. | 4 | $198 |
| Alexion Pharmaceuticals, Inc. | 3 | $136 |
| ANI Pharmaceuticals, Inc. | 4 | $135 |
| PFIZER INC. | 5 | $102 |
Products named: Bimzelx, SAPHNELO, SKYRIZI, COSENTYX, KRYSTEXXA, BENLYSTA, TAVNEOS, TREMFYA.
Industry payments across TX — which companies pay providers there.
